These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 19945487)

  • 21. Organization of the Flavivirus RNA replicase complex.
    Brand C; Bisaillon M; Geiss BJ
    Wiley Interdiscip Rev RNA; 2017 Nov; 8(6):. PubMed ID: 28815931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flavivirus NS3 and NS5 proteins interaction network: a high-throughput yeast two-hybrid screen.
    Le Breton M; Meyniel-Schicklin L; Deloire A; Coutard B; Canard B; de Lamballerie X; Andre P; Rabourdin-Combe C; Lotteau V; Davoust N
    BMC Microbiol; 2011 Oct; 11():234. PubMed ID: 22014111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The flavivirus capsid protein: Structure, function and perspectives towards drug design.
    Oliveira ERA; Mohana-Borges R; de Alencastro RB; Horta BAC
    Virus Res; 2017 Jan; 227():115-123. PubMed ID: 27751882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel Broad Spectrum Inhibitors Targeting the Flavivirus Methyltransferase.
    Brecher M; Chen H; Liu B; Banavali NK; Jones SA; Zhang J; Li Z; Kramer LD; Li H
    PLoS One; 2015; 10(6):e0130062. PubMed ID: 26098995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Broad-Spectrum Flavivirus Inhibitors: a Medicinal Chemistry Point of View.
    Felicetti T; Manfroni G; Cecchetti V; Cannalire R
    ChemMedChem; 2020 Dec; 15(24):2391-2419. PubMed ID: 32961008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug design for flavivirus proteases: what are we missing?
    Poulsen A; Kang C; Keller TH
    Curr Pharm Des; 2014; 20(21):3422-7. PubMed ID: 24001226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting dengue virus NS4B protein for drug discovery.
    Xie X; Zou J; Wang QY; Shi PY
    Antiviral Res; 2015 Jun; 118():39-45. PubMed ID: 25796970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular targets for flavivirus drug discovery.
    Sampath A; Padmanabhan R
    Antiviral Res; 2009 Jan; 81(1):6-15. PubMed ID: 18796313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flavivirus NS1: a multifaceted enigmatic viral protein.
    Rastogi M; Sharma N; Singh SK
    Virol J; 2016 Jul; 13():131. PubMed ID: 27473856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Viperin Restricts Zika Virus and Tick-Borne Encephalitis Virus Replication by Targeting NS3 for Proteasomal Degradation.
    Panayiotou C; Lindqvist R; Kurhade C; Vonderstein K; Pasto J; Edlund K; Upadhyay AS; Överby AK
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A conformational switch high-throughput screening assay and allosteric inhibition of the flavivirus NS2B-NS3 protease.
    Brecher M; Li Z; Liu B; Zhang J; Koetzner CA; Alifarag A; Jones SA; Lin Q; Kramer LD; Li H
    PLoS Pathog; 2017 May; 13(5):e1006411. PubMed ID: 28542603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Model System for the Formation of Tick-Borne Encephalitis Virus Replication Compartments without Viral RNA Replication.
    Yau WL; Nguyen-Dinh V; Larsson E; Lindqvist R; Överby AK; Lundmark R
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31243132
    [No Abstract]   [Full Text] [Related]  

  • 33. Crystal structure of the RNA polymerase domain of the West Nile virus non-structural protein 5.
    Malet H; Egloff MP; Selisko B; Butcher RE; Wright PJ; Roberts M; Gruez A; Sulzenbacher G; Vonrhein C; Bricogne G; Mackenzie JM; Khromykh AA; Davidson AD; Canard B
    J Biol Chem; 2007 Apr; 282(14):10678-89. PubMed ID: 17287213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An updated evolutionary study of Flaviviridae NS3 helicase and NS5 RNA-dependent RNA polymerase reveals novel invariable motifs as potential pharmacological targets.
    Papageorgiou L; Loukatou S; Sofia K; Maroulis D; Vlachakis D
    Mol Biosyst; 2016 Jun; 12(7):2080-93. PubMed ID: 26864387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond.
    Boldescu V; Behnam MAM; Vasilakis N; Klein CD
    Nat Rev Drug Discov; 2017 Aug; 16(8):565-586. PubMed ID: 28473729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease.
    Balasubramanian A; Manzano M; Teramoto T; Pilankatta R; Padmanabhan R
    Antiviral Res; 2016 Oct; 134():6-16. PubMed ID: 27539384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The VIZIER project: preparedness against pathogenic RNA viruses.
    Coutard B; Gorbalenya AE; Snijder EJ; Leontovich AM; Poupon A; De Lamballerie X; Charrel R; Gould EA; Gunther S; Norder H; Klempa B; Bourhy H; Rohayem J; L'hermite E; Nordlund P; Stuart DI; Owens RJ; Grimes JM; Tucker PA; Bolognesi M; Mattevi A; Coll M; Jones TA; Aqvist J; Unge T; Hilgenfeld R; Bricogne G; Neyts J; La Colla P; Puerstinger G; Gonzalez JP; Leroy E; Cambillau C; Romette JL; Canard B
    Antiviral Res; 2008 Apr; 78(1):37-46. PubMed ID: 18083241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Murine Efficacy and Pharmacokinetic Evaluation of the Flaviviral NS5 Capping Enzyme 2-Thioxothiazolidin-4-One Inhibitor BG-323.
    Bullard KM; Gullberg RC; Soltani E; Steel JJ; Geiss BJ; Keenan SM
    PLoS One; 2015; 10(6):e0130083. PubMed ID: 26075394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular Insights into the Flavivirus Replication Complex.
    van den Elsen K; Quek JP; Luo D
    Viruses; 2021 May; 13(6):. PubMed ID: 34064113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The dengue virus NS5 protein as a target for drug discovery.
    Lim SP; Noble CG; Shi PY
    Antiviral Res; 2015 Jul; 119():57-67. PubMed ID: 25912817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.